AlphaYouJG
Congress trade
Rep. Josh Gottheimer (D-NJ) bought $1K-$15K of Sarepta Therapeutics, Inc. (SRPT) stock
Josh Gottheimer, U.S. Representative (D-NJ), disclosed a purchase of Sarepta Therapeutics, Inc. (SRPT) stock worth $1K-$15K in a STOCK Act filing on Apr 20, 2023.
The trade happened on Mar 6, 2023, 45 days before it was made public.
SRPT has moved -88.8% since the trade date, from $155.99 to $17.50 (Oct 2, 2026 close).
- Traded
- Mar 6, 2023
- Disclosed
- Apr 20, 2023
- Filing delay
- 45 days
- Price since
- -88.8%
- Source
- STOCK Act disclosure
Other trades in this disclosure (44)
- SellFIS$15K-$50KApr 20, 2023
- SellAAPL$1K-$15KApr 20, 2023
- BuyABBV$1K-$15KApr 20, 2023
- SellABBV$1K-$15KApr 20, 2023
- SellABCB$1K-$15KApr 20, 2023
- BuyALGN$1K-$15KApr 20, 2023
- SellAMGN$1K-$15KApr 20, 2023
- SellAMGN$1K-$15KApr 20, 2023
- BuyAPPF$1K-$15KApr 20, 2023
- BuyASML$1K-$15KApr 20, 2023
- SellCCI$1K-$15KApr 20, 2023
- SellCOP$1K-$15KApr 20, 2023
- SellCOP$1K-$15KApr 20, 2023
- SellDE$1K-$15KApr 20, 2023
- SellGOOG$1K-$15KApr 20, 2023
- SellGOOG$1K-$15KApr 20, 2023
- SellGOOG$1K-$15KApr 20, 2023
- BuyHLN$1K-$15KApr 20, 2023
- SellKO$1K-$15KApr 20, 2023
- SellLLY$1K-$15KApr 20, 2023
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.